ADB-BUTINACA

ADB-BUTINACA
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Class B; US: Schedule I; UN: Psychotropic Schedule II;
Identifiers
	IUPAC name N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3-carboxamide;
CAS Number	2682867-55-4 ;
PubChem CID	155907792;
ChemSpider	81407832;
UNII	ZJ6LS4NVM9;
ChEMBL	ChEMBL5169682;
CompTox Dashboard (EPA)	DTXSID501342361 ;
Chemical and physical data
Formula	C18H26N4O2
Molar mass	330.432 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(N[C@H](C(N)=O)C(C)(C)C)C1=NN(CCCC)C2=C1C=CC=C2;
	InChI InChI=1S/C18H26N4O2/c1-5-6-11-22-13-10-8-7-9-12(13)14(21-22)17(24)20-15(16(19)23)18(2,3)4/h7-10,15H,5-6,11H2,1-4H3,(H2,19,23)(H,20,24)/t15-/m1/s1; Key:GPWADXHYJAZPAX-OAHLLOKOSA-N;

ADB-BUTINACA (also known as ADMB-BINACA using EMCDDA naming standards^[3]) is a synthetic cannabinoid compound which has been sold as a designer drug.^[4]^[5]^[6]^[7]^[8] It is a potent CB₁ agonist, with a binding affinity of 0.29nM for CB1 and 0.91nM for CB2, and an EC₅₀ of 6.36 nM for CB1.^[9]^[10]^[11]^[12]^[13]^[14]^[15]

Quick Facts Legal status, Identifiers ...

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[1]

[2]

ADB-BUTINACA

See also

References

Wikiwand - on